Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023
SKU ID : TNV-13753924 | Publishing Date : 27-Dec-2018 | No. of pages : 111
Detailed TOC of Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Consumables - Market size and forecast 2018-2023
• Systems - Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas - Market size and forecast 2018-2023
• EMEA - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: TRENDS
• Technological advancements
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMérieux
• F. Hoffmann-La Roche
• Quidel
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Years in consideration
Exhibit 02: Global in-vitro diagnostics (IVD) market
Exhibit 03: Segments of global in-vitro diagnostics (IVD) market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 22: Systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in EMEA
Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Decision framework
Exhibit 36: Product launches by companies
Exhibit 37: Product recalls
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott - Vendor overview
Exhibit 45: Abbott - Business segments
Exhibit 46: Abbott - Organizational developments
Exhibit 47: Abbott - Geographic focus
Exhibit 48: Abbott - Segment focus
Exhibit 49: Abbott - Key offerings
Exhibit 50: Abbott - Key customers
Exhibit 51: BD - Vendor overview
Exhibit 52: BD - Business segments
Exhibit 53: BD - Organizational developments
Exhibit 54: BD - Geographic focus
Exhibit 55: BD - Segment focus
Exhibit 56: BD - Key offerings
Exhibit 57: BD - Key customers
Exhibit 58: bioMérieux - Vendor overview
Exhibit 59: bioMérieux - Business segments
Exhibit 60: bioMérieux - Organizational developments
Exhibit 61: bioMérieux - Geographic focus
Exhibit 62: bioMérieux - Segment focus
Exhibit 63: bioMérieux - Key offerings
Exhibit 64: bioMérieux - Key customers
Exhibit 65: F. Hoffmann-La Roche - Vendor overview
Exhibit 66: F. Hoffmann-La Roche - Business segments
Exhibit 67: F. Hoffmann-La Roche - Organizational developments
Exhibit 68: F. Hoffmann-La Roche - Geographic focus
Exhibit 69: F. Hoffmann-La Roche - Segment focus
Exhibit 70: F. Hoffmann-La Roche - Key offerings
Exhibit 71: F. Hoffmann-La Roche - Key customers
Exhibit 72: Quidel - Vendor overview
Exhibit 73: Quidel - Product segments
Exhibit 74: Quidel - Organizational developments
Exhibit 75: Quidel - Geographic focus
Exhibit 76: Quidel - Segment focus
Exhibit 77: Quidel - Key offerings
Exhibit 78: Quidel - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: List of abbreviations
Keyplayers in Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023
AbbottBD
bioMérieux
F. Hoffmann-La Roche
Quidel